RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 88 filers reported holding RHYTHM PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,415,172 | +81.5% | 279,833 | +30.6% | 0.00% | 0.0% |
| Q2 2023 | $3,534,335 | -52.6% | 214,332 | -48.7% | 0.00% | 0.0% |
| Q1 2023 | $7,456,049 | +113.7% | 417,940 | +248.9% | 0.00% | – |
| Q4 2022 | $3,488,518 | -45.8% | 119,798 | -54.4% | 0.00% | -100.0% |
| Q3 2022 | $6,435,000 | +302.9% | 262,635 | -31.7% | 0.00% | – |
| Q2 2022 | $1,597,000 | -68.9% | 384,758 | -13.6% | 0.00% | -100.0% |
| Q1 2022 | $5,129,000 | +4479.5% | 445,224 | +3875.2% | 0.00% | – |
| Q4 2021 | $112,000 | -32.5% | 11,200 | -11.8% | 0.00% | – |
| Q3 2021 | $166,000 | -81.0% | 12,700 | -71.6% | 0.00% | – |
| Q2 2021 | $875,000 | -72.2% | 44,674 | -69.8% | 0.00% | -100.0% |
| Q1 2021 | $3,146,000 | -6.7% | 147,908 | +30.4% | 0.00% | 0.0% |
| Q4 2020 | $3,372,000 | +118.7% | 113,446 | +59.3% | 0.00% | – |
| Q3 2020 | $1,542,000 | +388.0% | 71,198 | +243.0% | 0.00% | – |
| Q1 2020 | $316,000 | -19.2% | 20,758 | +43.0% | 0.00% | – |
| Q4 2018 | $391,000 | -3.2% | 14,521 | +4.8% | 0.00% | – |
| Q3 2018 | $404,000 | -74.3% | 13,850 | -72.4% | 0.00% | -100.0% |
| Q2 2018 | $1,570,000 | +45.2% | 50,215 | -7.5% | 0.00% | 0.0% |
| Q1 2018 | $1,081,000 | -81.6% | 54,299 | -73.1% | 0.00% | -75.0% |
| Q4 2017 | $5,866,000 | – | 201,828 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
| NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
| Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
| Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
| VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
| RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
| Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
| Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
| Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |